DCF — HOLMES REGL MEDICAL CENTER
Enterprise Value: $-106.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-106.3M
Enterprise Value
$-49.2M
PV of Cash Flows
$-57.1M
PV of Terminal Value
$-92.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $610.8M | $4.6M | 1.0% | $-21.2M | $-19.3M |
| Year 2 | $629.2M | $11.0M | 2.0% | $-15.6M | $-12.9M |
| Year 3 | $648.0M | $17.9M | 3.0% | $-10.0M | $-7.5M |
| Year 4 | $667.5M | $21.7M | 3.0% | $-7.8M | $-5.3M |
| Year 5 | $687.5M | $24.1M | 4.0% | $-6.7M | $-4.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-106.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$593.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.002555961489758224
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5